Healthcare today fails because we lack early, non-invasive, population scale signals in primary care and other close to patient contexts, that can help risk triage those needing specialist care.
Remidio and the science of Oculomics is here to change that.
Healthcare today fails because we lack early, non-invasive, population scale signals in primary care and other close to patient contexts, that can help risk triage those needing specialist care.
Remidio and the science of Oculomics is here to change that.
Devices worldwide
Patients Screened
Countries
Served
Research Publications
Patents
Filed
GREY.png)
“Remidio’s products are a good fit to have in terms of ease of use and operational cost. Keep up the good work with innovative products.”
“I've been closely following a few of the products developed by Remidio for the last decade. Some of their technology, especially the Fundus On Phone, is very actively used in our vision centers. This device helps us a lot in preventing needless blindness among our patients.”
“The IRIS - Remidio partnership in the US has had a powerful impact on healthcare providers seeking to close care gaps and create better outcomes for their patients with diabetes. The Remidio device is portable, and takes high quality images making it much easier to provide sight-saving exams to patients with diabetes, in primary care and at home..”
Peenya Industrial Area, Phase-I,
Bangalore, Karnataka, India
Postal Code: 560 058
11357 Nuckols Road #102
Glen Allen, VA 23059
59 New Bridge Road, Singapore
059405
